Anakinra: Timely Targeted Anticytokine Therapy for Severe COVID-19

Among patients with elevated soluble urokinase plasminogen receptor levels, standard care plus anakinra increased full recovery and lowered mortality compared with standard care alone. Identifying patients at excess risk for severe COVID-19 is critical for devising treatment strategies (particularly those involving immune modulation) where early therapy is important. One predictor […]